Madrigal Pharmaceuticals Inc (MDGL) earnings · rev $958.4M
These earnings events as JSON? API free 100/dayMadrigal Pharmaceuticals Inc (MDGL) is a biotechnology company listed on NASDAQ.
This MDGL earnings page is the cached print — revenue, income, and the latest exhibit — not a live call transcript.
Latest reported MDGL revenue for 2025-12-31 was $958.4M. Net income was -$288.3M. Revenue was up 432.1% from 2024-12-31 to 2025-12-31. MDGL currently screens at market cap $11.56B.
When the next MDGL 8-K Item 2.02 lands, this page should move. Until then the SEC archive is the source.
The change that matters: Revenue was up 432.1% from 2024-12-31 to 2025-12-31. An earnings headline that ignores that move is noise.
Not investment advice. Full MDGL research stays on the stock page; the tape stays on the quote page.
MDGL earnings FAQ
What are MDGL's latest revenue and net income?
Latest cached Madrigal Pharmaceuticals Inc (MDGL) revenue for Dec 31, 2025 was $958.4M. Net income was -$288.3M. Statements: https://lician.com/financials/mdgl
What is MDGL's latest diluted EPS?
Latest cached Madrigal Pharmaceuticals Inc (MDGL) diluted EPS for Dec 31, 2025 was -$12.85.
What period does the latest MDGL earnings print cover?
The latest cached Madrigal Pharmaceuticals Inc (MDGL) earnings print covers Dec 31, 2025. The prior cached period on this page is Dec 31, 2024.
How did MDGL revenue change from the prior cached period?
Cached Madrigal Pharmaceuticals Inc (MDGL) revenue was up 432.1% from $180.1M (Dec 31, 2024) to $958.4M (Dec 31, 2025). Statements: https://lician.com/financials/mdgl
Where are MDGL earnings listed?
Cached earnings facts for Madrigal Pharmaceuticals Inc (MDGL) are listed at https://lician.com/earnings/mdgl. Statements: https://lician.com/financials/mdgl
Not investment advice.